Istamet® (Sitagliptin + Metformin Tablets) – 50/500 mg | 50/1000 mg

Istamet combines Sitagliptin + Metformin to improve blood sugar control in adults with Type2 diabetes.

Istamet® (Sitagliptin + Metformin Tablets) is a combination oral antidiabetic medicine used for the management of type 2 diabetes mellitus in adults. It combines Sitagliptin, a DPP-4 inhibitor that enhances incretin hormone activity, with Metformin, a biguanide that improves insulin sensitivity and reduces hepatic glucose production.

This dual-action therapy helps achieve better glycemic control in patients who are inadequately controlled on metformin alone. Istamet is commonly prescribed as part of a comprehensive diabetes management plan alongside diet and exercise.

Available strengths include 50 mg Sitagliptin + 500 mg Metformin and 50 mg Sitagliptin + 1000 mg Metformin, allowing flexible dosing based on individual patient requirements.

Medicina Overseas supplies Istamet® tablets for international export, supporting pharmacies, hospitals, wholesalers, and importers with bulk quantities, export-standard packaging, and regulatory documentation.

⚠️ Prescription medicine. Use only under medical supervision.

✅ KEY USES (OPTIONAL – IMPROVES CONVERSION)

• Management of type 2 diabetes mellitus

• Improves blood glucose control when metformin alone is insufficient

• Dual mechanism: insulin sensitivity + incretin enhancement

• Convenient oral combination therapy